Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6535768 | 0.86 | KDM4C (0.31) | KDM4CNPC1RAB9A | |
| SCHEMBL12435174 | 0.79 | MEN1 (0.36) | KDM4CNPC1RAB9AMEN1KMT2A | |
| SCHEMBL6534702 | 0.78 | KDM4C (0.34) | KDM4CNPC1RAB9AMEN1KMT2A | |
| SCHEMBL6166244 | 0.78 | KDM4C (0.37) | KDM4CNPC1RAB9AMEN1KMT2A | |
| SCHEMBL30407540 | 0.78 | KDM4C (0.37) | KDM4CNPC1RAB9AMEN1KMT2A | |
| SCHEMBL21738201 | 0.78 | MEN1 (0.42) | KDM4CNPC1RAB9AMEN1KMT2A | |
| SCHEMBL22495500 | 0.77 | MEN1 (0.37) | KDM4CNPC1RAB9AMEN1KMT2A | |
| SCHEMBL18095177 | 0.76 | MEN1 (0.37) | KDM4CNPC1RAB9AMEN1KMT2A | |
| SCHEMBL22517535 | 0.75 | KDM4C (0.34) | KDM4CNPC1RAB9AMEN1KMT2A | |
| SCHEMBL12435177 | 0.75 | MEN1 (0.39) | KDM4CNPC1RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6737124-B2 | ESPECIALLY DISILANES | DISPLAYTECH, INC. | 2004-05-18 | — | — | US | disclosed |
| US-20030003245-A1 | Liquid crystal compounds having a silane tail with a perfluoroalkyl terminal portion | CITIZEN FINETECH MIYOTA CO., LTD. (JP) | 2003-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030003245-A1 | Liquid crystal compounds having a silane tail with a perfluoroalkyl terminal portion | FFAR3, FFAR1, LPAR1 | KDM4C 2265/4885NPC1 393/4885RAB9A 1832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.